Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial evaluating acarbose and a mixture of pioglitazone and metformin for Type 2 Diabetes and blood glucose fluctuation.
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Statin and Bone Health [Phase 4]
Phase 4 clinical trial update investigating the relationship between statin use and bone health in patients with type 2 diabetes.
-
FDA approval · 2022-11-23FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy- [Phase 3]
Phase 3 trial update comparing BRL49653C monotherapy to pioglitazone and placebo in type 2 diabetes (completed).
-
FDA approval · 2022-11-17FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA granted a supplemental approval for TRULICITY (dulaglutide) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-16FDA Approved: REZVOGLAR KWIKPEN — Original Application (Eli Lilly and Company)
FDA approved Rezvoglar KwikPEN (insulin glargine-AGLR) from Eli Lilly as a biosimilar insulin glargine via an Original Application. It is in…
-
CLINICAL_TRIALS withdrawal · 2022-11-14Clinical Trial Update: Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity [Phase 3]
A Phase 3 clinical trial comparing semaglutide tablets with empagliflozin tablets for type 2 diabetes and obesity was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients [Phase 4]
A Phase 4 clinical trial update evaluating factors influencing 12-week efficacy of polyethylene glycol losenatide in type 2 diabetes patient…
-
CLINICAL_TRIALS research · 2022-11-10Clinical Trial Update: My Diabetes Care Mobile: A Usability Study [NA]
A usability study update for a mobile diabetes care tool in adults with Type 2 diabetes; completed with results posted.
-
FDA approval · 2022-11-08FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for bromocriptine mesylate from Sandoz Inc, approving a modification to an existing generic product'…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2. [Phase 2]
Phase 2 trial evaluating the combination of dapagliflozin and saxagliptin added to metformin versus saxagliptin or dapagliflozin alone in ty…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial evaluating oral insulin (ORMD-0801) for type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. [Phase 2]
A Phase 2 trial update evaluating HS-20004 for efficacy and safety in adults with Type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update for LY3209590 in type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating SGLT2 inhibitors for reduction of blood pressure by inhibiting urinary angiotensinogen in patients with type 2 diab…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial investigates how Nordic walking and exercise impact glucose metabolism in individuals with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device [Phase 2]
Phase 2 trial update for endoscopic sutured gastroplasty using the Endomina device in adults with type 2 diabetes and obesity.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk [Phase 3]
Phase 3 trial evaluating sotagliflozin in type 2 diabetes with moderate renal impairment at cardiovascular risk; study terminated with poste…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) [Phase 3]
Phase 3 SOLOIST-WHF trial assessing sotagliflozin effects on cardiovascular events in adults with type 2 diabetes and post-worsening heart f…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. [Phase 3]
Phase 3 trial completed evaluating long-term safety and efficacy of DWP16001 versus placebo in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial update on DWP16001 versus placebo for type 2 diabetes mellitus, reporting efficacy and safety results after completion.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of DWP16001 in combination with metformin in patients with type 2 diabetes mellitus has c…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin [Phase 3]
Phase 3 trial update evaluating long-term safety and efficacy of DWP16001 add-on to metformin in patients with type 2 diabetes inadequately …
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial update investigating metformin, dapagliflozin, and their combination with pioglitazone in patients with type 2 diabetes and in…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial comparing hydroxychloroquine vs pioglitazone in combination therapy for type 2 diabetes with hyperglycemia; study terminated w…